MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorOhio State University Comprehensive Cancer Center

About this trial

This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.

Eligibility criteria

Qualifiers

Adults ≥ 18 years old

Diagnosed with pancreatic adenocarcinoma undergoing active treatment or planning to start active treatment within the next 30 days

English speaking

Access to a smartphone (Android or iOS)

Disqualifiers

Prisoners

Patients undergoing cancer surveillance

Trial design

Treatments tested in this trial

  • Electronic Health Record Review
  • Smartphone Application-based Intervention
  • Survey Administration

Treatment groups

30 Participants
are divided into 1 treatment group

Locations

1
Ohio State University Comprehensive Cancer Center43210, ColumbusOhio, United States

Sponsors and collaborators

Ohio State University Comprehensive Cancer Center

Lead sponsor